Stay updated with breaking news from Presection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Final results from a phase 3 trial with the investigational DCVax-L vaccine show that overall survival was increased both in patients with newly diagnosed glioblastoma as well as recurrent disease.
Recovery occurred within 2 years in nearly three quarters of patients in a retrospective review at a single Chinese medical center.
The study shows that ctDNA testing could help guide decisions about adjuvant chemotherapy. The study was published as a preprint and has not yet been peer reviewed.
Among patients with metastatic colon cancer with liver or lung lesions who received neoadjuvant therapy, survival was longer in comparison with patients who received adjuvant therapy, but only in nonacademic settings.
The treatment combined surgical debulking and fractionated ablative laser for severe rhinophyma in three elderly individuals.